A&O advises on the financing of TPG Capital’s acquisition of DOC Generici
For media enquiries relating to this topic, please contact:
Headlines in this article
Related news and insights
News: 01 March 2024
Publications: 27 February 2024
Publications: 23 February 2024
Publications: 16 February 2024
Allen & Overy has advised on the financing supporting TPG Capital’s acquisition of DOC Generici, a leading manufacturer of generic pharmaceuticals in Italy, from ICG and Merieux Equity Partners.
A&O advised certain private credit funds on the issuance of Italian senior secured floating rate listed notes and certain other financial institutions on a multi-currency revolving credit facility.
London partners Robert Burt and Matt Moore led the leveraged finance offering, with support from senior associate John Donnelly and associates Adam Walsh, Diogo Casqueiro, Julius Greiner, Aditya Sarmah, Ryan Prithraj and Daniele Bossola. The Italian finance team was led by partner Pietro Scarfone, with assistance from associate Martina Gullino and trainee Riccardo Ingrao. Advice on Italian ICM matters was provided by Italian partner Cristiano Tommasi and counsel Alessandra Pala with the support from Edoardo Brugnoli and Italian tax aspects were handled by counsel Elia Ferdinando Clarizia and associates Simona Simone and Lino Ziliotti. Lux law support was provided by senior associates Lukas Vondrich and Joanna Bolanowska and associate Martin Poirier.